The Proteome and Genome Research Unit works on discovering and validating novel protein biomarkers involved in early diagnosis and prognosis in cancer. It also provides proteomics and genomics services thanks to state-of-the-art proteomics and genomics technologies.


The Proteome and Genome Research Unit has available a wide range of state-of-the-art proteomics and genomics technologies including various microarray platforms and the latest mass spectrometry platforms for clinical proteomics studies. The scientists within the unit have a strong expertise in molecular and cell biology techniques, biostatistics and bioinformatics. The research activities within the unit aim at delineating tumour cell heterogeneity and on the discovery and validation of novel protein biomarkers that are important for early diagnosis and prognosis in cancer. The unit provides also genomics and proteomics services at the national and international level.

Strategic research goals

  • Implement the latest technologies in genomics and proteomics research
  • Develop and implement state-of-the-art bioinformatics tools
  • Identification of new biological targets and biomarkers
  • Active collaboration with national and foreign institutions
  • Provide genomics and proteomics services to the scientific community


Gunnar Dittmar


1A-B, rue Thomas Edison
1445 Strassen
Tel. : +352 26970-944